In October 1995, following advice from the Committee on Safety of Medicines, the Department of Health issued a press release concerning the use of seven brands of combined oral contraceptive pills. All pills carry an increased risk of venous thromboembolic events," though the absolute risk is low and considerably less than the health risks associated with an unwanted pregnancy or abortion. Recent studies345 suggest that newer pills, containing desogestrel or gestodene, are associated with higher rates of thrombosis. Immediate effect ofpill safety scare on oral contraceptive use period 1-17 October 1995. Also, continuing users of second-generation pills would have required 114000 items during the quarter. The remaining 26000 third-generation and 113000 second-generation items are attributable to prescribing, in the period following the health announcement, for 180 000 women who had previously used third-generation pills. However, only about 54% of women who continued using the reviewed brands would have needed a new prescription before the end of December. This suggests around 48 000 (= 26 000/0.54) women continuing to use third generation pills after doctor consultation. Prescribing for 19,000 previous users (10.5%, or 5.6% of total users) is unaccounted for-they may have continued to use previously dispensed supplies of the reviewed brands without yet consulting their doctors, or they may be using alternative contraceptive methods or have ceased contraception.
Comment
The abrupt change in contraceptive advice for over half the women taking the pill has had a substantial immediate impact on the types of pills prescribed, and there are preliminary indications that up to 5% of users may have stopped using effective contraception, albeit temporarily. Consequently, overall health risks may have risen in the short term. To realise the long term health benefits of any decreased thrombosis risk, the overwhelming majority of previous pill users must adopt reliable alternative contraception. Anticipating public perceptions of risk, and consequential behavioural changes is difficult. Would the same information presented as "lower risk associated with older brands" have had the same outcome? 
